Eligibility
To be eligible, products must have received marketing aproval in the USA by December 31 of the year preceding the award, but not more than 5 years earlier than December 31 of that year, unless the award is for a new and innovative indication, which must have been added within the previous 5 years.
The pharmaceutical, biotechnology, diagnostics and medical device products considered for the Prix Galien USA Award must be fully FDA approved (provisional approvals are not sufficient).
Award categories:
As many as three awards will be given for each of the following categories:
- • Best Pharmaceutical Agent
- • Best Biotechnology Product
- • Best Medical Technology
Jury Submission Criteria
- 1. Was it innovative in the course of its scientific development, application or clinical utility?
- 2. Was its discovery heuristic? Did we learn anything for the future of biomedical science from its introduction to the clinic?